Cover Image

PAPERBACK
$29.75



View/Hide Left Panel

Acronyms

Akt protein kinase B

ALS amyotrophic lateral sclerosis

C-Path Critical Path Institute

caBIG cancer Biomedical Informatics Grid

CEO chief executive officer

CERN European Organization for Nuclear Research

CMS Centers for Medicare & Medicaid Services

EBI European Bioinformatics Institute

EMEA European Medicines Agency

FDA Food and Drug Administration

FDG-PET flurodeoxyglucose-positron emission tomography

FNIH Foundation for the National Institutes of Health

I-SPY 2 TRIAL Inspection of Serial studies to Predict Your Therapeutic Response with Imaging And moLecular analysis 2

IGFR insulin-like growth factor receptor

IMI Innovative Medicines Initiative

IND investigational new drug

IP intellectual property



The National Academies | 500 Fifth St. N.W. | Washington, D.C. 20001
Copyright © National Academy of Sciences. All rights reserved.
Terms of Use and Privacy Statement



Below are the first 10 and last 10 pages of uncorrected machine-read text (when available) of this chapter, followed by the top 30 algorithmically extracted key phrases from the chapter as a whole.
Intended to provide our own search engines and external engines with highly rich, chapter-representative searchable text on the opening pages of each chapter. Because it is UNCORRECTED material, please consider the following text as a useful but insufficient proxy for the authoritative book pages.

Do not use for reproduction, copying, pasting, or reading; exclusively for search engines.

OCR for page 85
Acronyms Akt protein kinase B ALS amyotrophic lateral sclerosis C-Path Critical Path Institute caBIG cancer Biomedical Informatics Grid CEO chief executive officer CERN European Organization for Nuclear Research CMS Centers for Medicare & Medicaid Services EBI European Bioinformatics Institute EMEA European Medicines Agency FDA Food and Drug Administration FDG-PET flurodeoxyglucose-positron emission tomography FNIH Foundation for the National Institutes of Health I-SPY 2 TRIAL Inspection of Serial studies to Predict Your Therapeutic Response with Imaging And moLecular analysis 2 IGFR insulin-like growth factor receptor IMI Innovative Medicines Initiative IND investigational new drug IP intellectual property 

OCR for page 85
 PRECOMPETITIVE COLLABORATION IN ONCOLOGY RESEARCH IRB institutional review board IT information technology MEK mitogen-activated protein kinase 1 MIT Massachusetts Institute of Technology MMRF Multiple Myeloma Research Foundation MRF Myelin Repair Foundation NCI National Cancer Institute NHGRI National Human Genome Research Institute NIH National Institutes of Health NME new molecular entity OBQI Oncology Biomarker Qualification Initiative OSDD Open Source Drug Discovery PI3K phosphatidylinositol-3 kinase PMA premarket approval R&D research and development SEMATECH SEmiconductor MAnufacturing TECHnology START Standard Terms of Agreement for Research Trial TCGA The Cancer Genome Atlas UCSF University of California–San Francisco